Koichi Mandai
Impact in
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Medical Imaging and Pathology Studies
- Gastric Cancer Management and Outcomes
- Oncology top 10%
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
Papers in
-
- Lung Cancer Diagnosis and Treatment 6
- Oncology 21
- Lung Cancer Research Studies 5
- Peptidase Inhibition and Analysis 5
- Co-authors
- Yoshihiko Segawa (13 shared papers)Kenji Eguchi (10 shared papers)Masao Nakata (10 shared papers)Hideyuki Saeki (9 shared papers)Ichiro Takata (7 shared papers)H Mogami (3 shared papers)Shigemitsu Takashima (13 shared papers)Minoru Tanada (6 shared papers)
- Journals
- Japanese Journal of Clinical Oncology (5 papers)Breast Cancer (4 papers)International Journal of Oncology (3 papers)Lung Cancer (3 papers)Modern Rheumatology (2 papers)
- Partner nations
- JapanUnited StatesSweden
In The Last Decade
Koichi Mandai
58 papers receiving 856 citations
Peers
Comparison fields: 5 of 72
- Pulmonary and Respiratory Medicine 359
- Oncology 205
- Hepatology 52
- Gastroenterology 22
- Microbiology 3
Countries citing papers authored by Koichi Mandai
This map shows the geographic impact of Koichi Mandai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichi Mandai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichi Mandai more than expected).
Fields of papers citing papers by Koichi Mandai
This network shows the impact of papers produced by Koichi Mandai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichi Mandai. The network helps show where Koichi Mandai may publish in the future.
Co-authors
The 25 scholars most cited alongside Koichi Mandai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 222 | |
| 2 | 1995 | 72 | |
| 3 | Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung. | 2002 | 56 |
| 4 | 2006 | 35 | |
| 5 | Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer. | 2000 | 35 |
| 6 | 1992 | 27 | |
| 7 | 2002 | 25 | |
| 8 | 1994 | 23 | |
| 9 | 1999 | 22 | |
| 10 | 1993 | 21 | |
| 11 | 2006 | 21 | |
| 12 | 2003 | 20 | |
| 13 | 1997 | 20 | |
| 14 | 1998 | 16 | |
| 15 | 1984 | 15 | |
| 16 | 2007 | 14 | |
| 17 | 2003 | 14 | |
| 18 | 1999 | 12 | |
| 19 | 2002 | 12 | |
| 20 | Gastric adenocarcinomas in displaced mucosal glands. | 1999 | 12 |
About Koichi Mandai
Koichi Mandai is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Epidemiology and Molecular Biology, having authored 62 papers that have together received 878 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Lung Cancer Diagnosis and Treatment (6 papers), Neuroendocrine Tumor Research Advances (6 papers), Lung Cancer Research Studies (5 papers), Peptidase Inhibition and Analysis (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Multiple and Secondary Primary Cancers (4 papers) and Gastrointestinal disorders and treatments (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (359 citations), Oncology (205 citations), Hepatology (52 citations), Gastroenterology (22 citations) and Microbiology (3 citations). Koichi Mandai has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Yoshihiko Segawa, Kenji Eguchi, Masao Nakata, Hideyuki Saeki, Ichiro Takata, H Mogami, Shigemitsu Takashima, Minoru Tanada, Nagio Takigawa and Carlos Rubio‐Terres. Their work appears in journals such as Japanese Journal of Clinical Oncology, Breast Cancer, International Journal of Oncology, Lung Cancer and Modern Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.